Spots Global Cancer Trial Database for head cancer
Every month we try and update this database with for head cancer cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
Response to Intermittent Pneumatic Compression Therapy in Head and Neck Cancer-Related Lymphedema | NCT02946021 | Head and Neck N... Head and Neck L... Head and Neck C... | Head and neck g... NIRFLI with ICG | 18 Years - | Tactile Medical | |
Association Between Tinnitus and Hearing Loss in Locally Advanced Head and Neck Cancer Treated by Radiotherapy Alone or With Chemotherapy: a Prospective and Multicenter Study | NCT05946577 | Head Cancer Neck Cancer | 18 Years - | Assistance Publique - Hôpitaux de Paris | ||
Study Comparing Lymphoseek® vs. Albumin Nanocolloid in Head and Neck, Melanoma and Breast Cancer | NCT04261179 | Head Cancer Neck Cancer Melanoma Breast Cancer | Lymphoseek Nanocoll | 18 Years - | Fundacion Clinic per a la Recerca Biomédica | |
Neurosensorial Disorder and Pain in Oral Cavity and Oropharynx Cancer Traited Patients (OCAPA) | NCT04673981 | Head Cancer Neck Cancer Chronic Pain | diagnostic tes ... | 18 Years - | University Hospital, Clermont-Ferrand | |
ZD1839 (IRESSA™) in Combination With Docetaxel & Cisplatin in Subjects With Metastatic Head & Neck Cancer | NCT00242762 | Head and Neck C... | ZD1839 (IRESSA™... Docetaxel Cisplatin | 18 Years - 70 Years | AstraZeneca | |
Commensal Oral Microbiota in Head and Neck Cancer | NCT03843554 | Head and Neck C... Oral Mucositis | Standard of Car... Oral mucosal de... | 18 Years - | University of Pennsylvania | |
Predicting Tolerance to Radiation Therapy in Older Adults With Cancer | NCT01752751 | Pre-treatment L... | 65 Years - | UNC Lineberger Comprehensive Cancer Center | ||
IRESSA in Combination With Cisplatin & Radiotherapy in Patients With Advanced Head & Neck Carcinoma | NCT00242749 | Cancer of Head ... | Gefitinib, Cisp... | 18 Years - 70 Years | AstraZeneca | |
Study in Advanced Solid Tumors | NCT01099358 | Solid Tumor | Cetuximab Cisplatin 5 - Fluorouraci... | 18 Years - | Eli Lilly and Company | |
Transcutaneous Electrical Nerve Stimulation (TENS) and Head and Neck Cancer Pain (HNC) (TENS & HNC) | NCT01194466 | Head Cancer Neck Cancer Pain | Transcutaneous ... | 18 Years - 90 Years | University of Iowa | |
Neurosensorial Disorder and Pain in Oral Cavity and Oropharynx Cancer Traited Patients (OCAPA) | NCT04673981 | Head Cancer Neck Cancer Chronic Pain | diagnostic tes ... | 18 Years - | University Hospital, Clermont-Ferrand | |
Study of Albumin Bound-Paclitaxel for Treatment of Recurrent or Metastatic Head and Neck Cancer With Cetuximab | NCT00319839 | Head and Neck C... | Abraxane Cetuximab | 18 Years - | University of California, Irvine | |
Cisplatin and Docetaxel Plus Docetaxel and Radiotherapy With Amifostine for Squamous Cell Carcinoma of the Head and Neck | NCT00318890 | Cancer of Head ... Head Cancer Head and Neck C... Neck Cancer Neck Neoplasms | Cisplatin Docetaxel Radiotherapy Amifostine | 19 Years - | University of Alabama at Birmingham | |
Impact of Selective Radiation Dose Escalation and Tumour Hypoxia Status on Locoregional Tumour Control After Radiochemotherapy of HNT | NCT01212354 | Locally Advance... | Radiotherapy | 18 Years - 70 Years | Technical University of Munich | |
Roll-over Study to Continue Treatment With the Investigational Drug Rogaratinib and to Further Test Its Safety | NCT04125693 | Cancer | Rogaratinib (BA... Combination dru... | 18 Years - | Bayer | |
Education, Immigration and HPV Vaccination: an Informational Randomized Trial | NCT04905030 | Cervical Cancer Vulvar Cancer Anus Cancer Penis Cancer Mouse Papilloma Head Cancer Genital Wart Neck Cancer | Information T1 Information T2 Information C | - | Karolinska Institutet | |
DNA Repair Enzyme Signature in Head and Neck Cancer (CHEMRAD) | NCT02714920 | Head Cancer Neck Cancer | CHEMRAD assay | 18 Years - | Hospices Civils de Lyon | |
Phase II Trial of Allovectin-7® for Head and Neck Cancer | NCT00050388 | Head and Neck C... Squamous Cell C... Head and Neck N... Carcinoma of th... | Allovectin-7® | 18 Years - | Vical | |
Evaluation of Quality of Life and Self-assurance and Social Support Earned for Non-cellular Head Cancer | NCT06395805 | Head Cancer | BREF, ADL, AIS. | - | Andrzej Frycz Modrzewski Krakow University | |
Impact of Selective Radiation Dose Escalation and Tumour Hypoxia Status on Locoregional Tumour Control After Radiochemotherapy of HNT | NCT01212354 | Locally Advance... | Radiotherapy | 18 Years - 70 Years | Technical University of Munich | |
IRESSA in Combination With Cisplatin & Radiotherapy in Patients With Advanced Head & Neck Carcinoma | NCT00242749 | Cancer of Head ... | Gefitinib, Cisp... | 18 Years - 70 Years | AstraZeneca | |
A Study in Advanced Solid Tumors | NCT01063075 | Solid Tumor | Cetuximab Carboplatin 5 - FU | 18 Years - | Eli Lilly and Company | |
Laser Therapy for the Prevention of Radiodermatitis in Head and Neck Patients | NCT02738268 | Head Cancer Neck Cancer | Low-level laser... sham laser | - | Hasselt University | |
Oral AHR Antagonist in Combination With Nivolumab in Patients With PD-1 Resistant Metastatic or Recurrent Head and Neck Cancer | NCT05472506 | Head and Neck S... Head and Neck C... Head Cancer Neck Cancer Head Cancer Nec... Neck Carcinoma | IK-175 + nivolu... | 18 Years - | Ikena Oncology | |
ZD1839 (IRESSA™) in Combination With Docetaxel & Cisplatin in Subjects With Metastatic Head & Neck Cancer | NCT00242762 | Head and Neck C... | ZD1839 (IRESSA™... Docetaxel Cisplatin | 18 Years - 70 Years | AstraZeneca | |
A Pilot Study to Evaluate the Feasibility and Potential Effectiveness of the Flexitouch System Head and Neck Treatment | NCT03332160 | Head and Neck N... Head and Neck C... Head and Neck L... | Flexitouch head... Standard home l... | 18 Years - | Tactile Medical | |
Study of Albumin Bound-Paclitaxel for Treatment of Recurrent or Metastatic Head and Neck Cancer With Cetuximab | NCT00319839 | Head and Neck C... | Abraxane Cetuximab | 18 Years - | University of California, Irvine | |
Study Comparing Lymphoseek® vs. Albumin Nanocolloid in Head and Neck, Melanoma and Breast Cancer | NCT04261179 | Head Cancer Neck Cancer Melanoma Breast Cancer | Lymphoseek Nanocoll | 18 Years - | Fundacion Clinic per a la Recerca Biomédica | |
HPV DNA-Guided Radiotherapy De-intensification of Head and Neck Squamous Cell Carcinoma | NCT05962242 | Squamous Cell C... | Radiation Thera... | 18 Years - | University of Virginia | |
Dynamic Contrast Enhanced MRI (DCE-MRI) Diffusion Weighted MRI (DW-MRI) and Magnetic Resonance Spectroscopy (MRS) of Head and Neck Tumors | NCT00581906 | Head and Neck C... | DCE-MRI, DW-MRI... | 18 Years - | Memorial Sloan Kettering Cancer Center | |
Study in Advanced Solid Tumors | NCT01099358 | Solid Tumor | Cetuximab Cisplatin 5 - Fluorouraci... | 18 Years - | Eli Lilly and Company | |
Study of Albumin Bound-Paclitaxel for Treatment of Recurrent or Metastatic Head and Neck Cancer With Cetuximab | NCT00319839 | Head and Neck C... | Abraxane Cetuximab | 18 Years - | University of California, Irvine | |
HPV DNA-Guided Radiotherapy De-intensification of Head and Neck Squamous Cell Carcinoma | NCT05962242 | Squamous Cell C... | Radiation Thera... | 18 Years - | University of Virginia | |
A Study of Pembrolizumab in Combination With Chemotherapy for Head and Neck Cancer | NCT05420948 | Head and Neck C... Head and Neck S... Head and Neck N... Head Cancer Throat Carcinom... | Pembrolizumab Carboplatin Paclitaxel | 18 Years - | University of Chicago | |
A Study of Pembrolizumab in Combination With Chemotherapy for Head and Neck Cancer | NCT05420948 | Head and Neck C... Head and Neck S... Head and Neck N... Head Cancer Throat Carcinom... | Pembrolizumab Carboplatin Paclitaxel | 18 Years - | University of Chicago | |
Structure and Functional Status of Parotid Glands Exposed to Therapeutic Irradiation | NCT00001523 | Radiation Injur... Xerostomia | - | National Institutes of Health Clinical Center (CC) |